Growth Metrics

Evolent Health (EVH) Gross Profit (2016 - 2025)

Evolent Health (EVH) has 11 years of Gross Profit data on record, last reported at $99.8 million in Q3 2025.

  • For Q3 2025, Gross Profit rose 23.65% year-over-year to $99.8 million; the TTM value through Sep 2025 reached $378.3 million, down 3.8%, while the annual FY2024 figure was $367.4 million, 20.22% down from the prior year.
  • Gross Profit reached $99.8 million in Q3 2025 per EVH's latest filing, down from $100.4 million in the prior quarter.
  • Across five years, Gross Profit topped out at $124.4 million in Q3 2023 and bottomed at $49.9 million in Q2 2021.
  • Average Gross Profit over 5 years is $89.3 million, with a median of $86.0 million recorded in 2022.
  • Peak YoY movement for Gross Profit: soared 66.87% in 2023, then plummeted 35.15% in 2024.
  • A 5-year view of Gross Profit shows it stood at $83.9 million in 2021, then dropped by 0.97% to $83.1 million in 2022, then grew by 22.35% to $101.6 million in 2023, then dropped by 25.5% to $75.7 million in 2024, then soared by 31.78% to $99.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $99.8 million in Q3 2025, $100.4 million in Q2 2025, and $102.5 million in Q1 2025.